Back to company

Core Med Tech Development ApS: Financial statements 2024

CVR: 37703788

Core Med Tech Development ApS (CVR 37703788) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -84,878 and a net result of DKK 1,645,725 compared with DKK 1,222,609 the year before. Equity amounted to DKK 16,106,379. The solvency ratio was 97.6%.

Gross Profit
-84,878 kr.
Profit/Loss
1,645,725 kr.
Equity
16,106,379 kr.
Total Assets
16,496,557 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--85 t.1.6 mio.16.1 mio.-
2023--32 t.1.2 mio.16 mio.-
2022--13 t.-4.3 mio.16.7 mio.-
2021--1.8 mio.36 mio.27.1 mio.-
2020--52 t.1.9 mio.16.1 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Core Med Tech Development ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About Core Med Tech Development ApS

Core Med Tech Development ApS is a Danish company of the type Anpartsselskab based in Allerød, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Steffen Vogel and Christian Schärfe Baltzer-Thomsen. The company is owned by SASSER G HOLDING ApS and Baltho Holding ApS. In 2025, the company reported a gross profit of DKK -220,933 and a net result of DKK -99,037 compared with DKK 1,645,725 the year before. Equity amounted to DKK 15,007,343.